Skip to content
10-K

Annual Report

BioCrude Technologies USA, Inc.

0001731122-23-000488

← back to feed
Filed
Mar 29, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Mar 29, 2023 50.77M sh
Long Term Debt FY 2022 · Dec 31, 2022 $101.35K
Long Term Debt FY 2022 · Dec 31, 2021 $91.62K
Capex FY 2022 · Dec 31, 2021 $5.09K
Operating Cash Flow FY 2022 · Dec 31, 2021 −$310.27K
Short Term Debt FY 2022 · Dec 31, 2021 $113.06K
Stockholders Equity FY 2022 · Dec 31, 2021 −$171.26K
Current Liabilities FY 2022 · Dec 31, 2021 $196.48K
Total Liabilities FY 2022 · Dec 31, 2021 $196.48K
Current Assets FY 2022 · Dec 31, 2021 $1.78K
Total Assets FY 2022 · Dec 31, 2021 $22.63K
Sga Expense FY 2022 · Dec 31, 2021 $427.33K
Operating Income FY 2022 · Dec 31, 2021 −$427.33K